Cerus Corporation

NASDAQ:CERS

Medical - Devices

Healthcare
$1.90 +2.92%

+$0.08 today

Market cap
$383.71M
Beta
1.77
P/E (TTM)
-53.8
EPS (TTM)
-$0.05
52W Low $1.15High $3.15

Volume 6.69M

Average 2.33M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$11.36M

FY 2025 · Annual

+0.0% YoY

Investing Cash Flow

-$8.13M

FY 2025 · Annual

Financing Cash Flow

$4.96M

FY 2025 · Annual

+0.0% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(54.38M)(42.83M)(37.49M)(20.96M)(15.63M)
Depreciation & Amortization3.15M2.98M2.6M1.86M1.86M
Deferred Income Tax462K0000
Stock-Based Compensation23.57M24.46M20.27M22.87M22.87M
Change in Working Capital(9.4M)(16.05M)(32.04M)5.23M(6.83M)
Accounts Receivables(4.22M)(9.2M)(1.1M)5.5M(396K)
Inventory(19.61M)(1.77M)(14.95M)7.03M(14.68M)
Accounts Payables12.2M(4.91M)(7.34M)(1.48M)5.73M
Other Working Capital2.22M(179K)(8.65M)(5.83M)2.52M
Other Non-Cash Items2.67M5.82M3.49M2.37M9.09M
Operating Cash Flow(33.92M)(25.62M)(43.17M)11.36M11.36M
Capital Expenditures(910K)(2M)(4.6M)(2.84M)(2.84M)
Acquisitions (Net)910K(10.46M)000
Purchases of Investments(52.07M)(29.64M)(2.49M)(42.98M)(42.98M)
Sales of Investments65.66M40.1M15.71M37.68M37.68M
Other Investing Activities(910K)10.46M000
Investing Cash Flow12.69M8.46M8.62M(8.13M)(8.13M)
Debt Repayment21.18M212K9.92M4.3M(329K)
Common Stock Issued2.74M000560K
Common Stock Repurchased0(104K)(175K)00
Dividends Paid00000
Other Financing Activities10.37M4.08M925K667K4.73M
Financing Cash Flow34.29M4.19M10.67M4.96M4.96M
Effect of Forex Changes(919K)(727K)(128K)(191K)(191K)
Net Change in Cash12.14M(13.69M)(24M)8M8M
Free Cash Flow(34.83M)(27.62M)(47.77M)8.52M8.52M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$15.6M
+ D&A$1.9M
+ Stock-Based Comp$22.9M
+ Deferred Tax$0
- Working Capital-$6.8M
+ Other Non-Cash$9.1M
= Operating Cash Flow$11.4M
- Capex-$2.8M
= Free Cash Flow$8.5M

Analysis

FY2025 free cash flow is $8.5M. FCF conversion is -54.5% of net income. Operating cash flow was $11.4M, with capex of -$2.8M. The largest bridge item is Stock-Based Comp at $22.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
S-3S-3 filingNov 2, 2026
8-KCurrent reportNov 2, 2026
10-QQuarterly reportNov 2, 2026
4Statement of changes in beneficial ownershipAug 17, 2026

Does CERS generate free cash flow?

Cerus Corporation (CERS) generated $8.52M of free cash flow in fiscal 2025.

How much operating cash flow does CERS produce?

Operating cash flow was $11.36M, before capital expenditures of $2.84M.